These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15877725)

  • 1. Therapeutic approaches in metastatic renal cell carcinoma.
    Staehler M; Rohrmann K; Bachmann A; Zaak D; Stief CG; Siebels M
    BJU Int; 2005 Jun; 95(8):1153-61. PubMed ID: 15877725
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal cell carcinoma.
    Mulders PF
    World J Urol; 2008 Apr; 26(2):113. PubMed ID: 18389254
    [No Abstract]   [Full Text] [Related]  

  • 3. What's new in the treatment of metastatic kidney cancer?
    Mancuso A; Sternberg CN
    BJU Int; 2005 Jun; 95(9):1171-80. PubMed ID: 15892796
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy for renal cell cancer.
    Yang JC; Childs R
    J Clin Oncol; 2006 Dec; 24(35):5576-83. PubMed ID: 17158543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapeutic approaches for renal cancer.
    Pizza G; de Vinci C; Viza D
    Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765
    [No Abstract]   [Full Text] [Related]  

  • 6. Current immunotherapeutic strategies in renal cell carcinoma.
    Amato RJ
    Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New treatments for renal cell carcinoma: hope and limits].
    Bodner A; Pelte MF; Verbist MC; Dietrich PY
    Rev Med Suisse; 2007 May; 3(112):1288, 1290-2, 1294 passim. PubMed ID: 17596064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metastatic kidney cancer: new therapeutic approaches].
    Negrier S; Mejean A; Oudard S; Escudier B
    Prog Urol; 2002 Sep; 12(4):703-8. PubMed ID: 12463140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of metastatic renal cell cancer.
    Fishman M; Seigne J
    Cancer Control; 2002; 9(4):293-304. PubMed ID: 12228755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lower dose of thalidomide is better than a high dose in metastatic renal cell carcinoma.
    Srinivas S; Guardino AE
    BJU Int; 2005 Sep; 96(4):536-9. PubMed ID: 16104906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous adrenalectomy during radical nephrectomy for renal cell carcinoma will not cure patients with adrenal metastasis.
    von Knobloch R; Schrader AJ; Walthers EM; Hofmann R
    Urology; 2009 Feb; 73(2):333-6. PubMed ID: 19038420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
    Driessens G; Hoffmann P; Pouwels M; Zlotta A; Schulman C; Velu T; Bruyns CA
    J Immunother; 2009; 32(2):140-4. PubMed ID: 19238012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The advantages of antiangiogenics in neoadjuvant and adjuvant locally advanced and metastatic kidney cancer: two case studies].
    Ferrière JM; Wallerand H; Bernhard JC; Cornu JN; Rouprêt M; Ravaud A
    Prog Urol; 2008 Jul; 18 Suppl 4():S88-91. PubMed ID: 18706377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term tumor cell lines from renal cell carcinoma for use as autologous tumor cell vaccines in the treatment of kidney cancer.
    Dillman RO; Beutel LD; Cornforth AN; Nayak SK
    Cancer Biother Radiopharm; 2000 Apr; 15(2):161-8. PubMed ID: 10803321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immunotherapy in metastatic renal cell carcinoma.
    Cho YH; Kim MS; Chung HS; Hwang EC
    Investig Clin Urol; 2017 Jul; 58(4):220-227. PubMed ID: 28681030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open surgical management of renal cell carcinoma in the era of minimally invasive kidney surgery.
    Dave DS; Lam JS; Leppert JT; Belldegrun AS
    BJU Int; 2005 Dec; 96(9):1268-74. PubMed ID: 16287443
    [No Abstract]   [Full Text] [Related]  

  • 18. New therapeutic developments in renal cell cancer.
    Prenen H; Gil T; Awada A
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors in kidney cancer].
    Patard JJ
    Prog Urol; 2007 Feb; 17(1 Suppl 1):139-43. PubMed ID: 17571637
    [No Abstract]   [Full Text] [Related]  

  • 20. EORTC-GU group expert opinion on metastatic renal cell cancer.
    de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
    Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.